CARE Ratings Q1 FY27 Results: Revenue Rs 111 Cr, PAT Rs 32 Cr and Key Highlights

CARE Ratings Q1 FY27 results declared August 7, 2026. Revenue Rs 111 Cr (+18.93% YoY). PAT Rs 32 Cr (+24.51% YoY). CMP Rs 1749.2 (+1.1%).

Updated: 10 Aug 2026 • 5:00 pm

Posted by:

CARE Ratings Q1 FY27 results were declared on August 7, 2026, consolidated. Revenue grew +18.93% YoY to Rs 111 Cr from Rs 93 Cr in Q1 FY26. The broader Nifty Fin Service index reflected mixed sectoral sentiment during the quarter.

Operating profit stood at Rs 30 Cr (+26.43% YoY). PAT came in at Rs 32 Cr (+24.51% YoY), providing a detailed view of CARE Ratings Q1 FY27 results and business performance.

Click Here – Get Free Investment Predictions

CARE Ratings Q1 FY27 Financial Highlights

Metric	Q1 FY27 (Rs Cr)	Q1 FY26 (Rs Cr)	YoY Change
CARE Ratings Revenue	111	93	+18.93%
Operating Profit	30	24	+26.43%
Net Profit (PAT)	32	26	+24.51%
Reporting Basis	Consolidated

CARE Ratings Q1 FY27 Performance Analysis

Check the Univest Screener for Live Data on This Stock

CARE Ratings Q1 FY27 results reflect healthy fundamentals across key financial metrics. The top line showed resilience with revenue reaching Rs 111 Cr for the April to June 2026 quarter.

Operating profit expanded +26.43% YoY to Rs 30 Cr. Improving cost absorption and product mix optimisation contributed to the uptick.

PAT of Rs 32 Cr in CARE Ratings Q1 FY27 results marks a +24.51% YoY movement. Investors monitoring CARE Ratings Q1 FY27 results will note this as a key milestone for the FY27 earnings trajectory.

Key Business Factors in CARE Ratings Q1 FY27 Results

Revenue Growth Momentum in the Quarter

CARE Ratings Q1 FY27 results show top-line expansion of +18.93% YoY to Rs 111 Cr. Order book execution and market share gains in the Financial Services segment supported this trajectory.

Operating Margin Performance

Operating profit in CARE Ratings Q1 FY27 results improved to Rs 30 Cr (+26.43% YoY). Better product mix, cost discipline, and operating leverage contributed to the improvement.

PAT Trajectory and Profitability Outlook

PAT in CARE Ratings Q1 FY27 results stood at Rs 32 Cr (+24.51% YoY). The improving PAT trajectory signals strengthening financial health and returns on capital.

Dividend Details

No dividend was declared alongside CARE Ratings Q1 FY27 results. Earnings are being directed toward operational investments and working capital optimisation.

FY27 Outlook for CARE Ratings

CARE Ratings is positioned to sustain growth momentum through FY27 driven by order visibility, sector tailwinds, and operational improvements in the financial services segment. Management guidance points toward continued focus on margin expansion. Investors tracking CARE Ratings Q1 FY27 results should consult a SEBI-registered financial advisor before making investment decisions.

CARE Ratings Stock Performance After Q1 FY27 Results

Download the Univest iOS App or Univest Android App to track CARE Ratings live price and get daily stock recommendations.

CARE Ratings shares were trading higher at Rs 1749.2 (+1.1%) on August 7, 2026, reflecting investor sentiment on CARE Ratings Q1 FY27 results and the near-term sector outlook. The CMP of Rs 1749.2 on the results date reflects broader sentiment in the financial services space.

Key Risks for CARE Ratings

Sector-Specific Risks

Regulatory tightening and competitive intensity in credit rating business.

Valuation and Earnings Risk

Valuation risk remains if quarterly growth momentum fails to sustain over the next two to three quarters.

Operational and Financial Risk

Subsidiary-level underperformance could drag consolidated PAT lower in subsequent quarters.

Conclusion

CARE Ratings Q1 FY27 results reflect healthy performance with revenue at Rs 111 Cr and PAT at Rs 32 Cr on a Consolidated basis. Sector tailwinds and operational discipline will determine the FY27 growth trajectory. Investors should review management commentary and quarterly data before taking any position.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).